Tracking the common ancestry of antigenically distinct cancer variants

Clinical Cancer Research

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Schreiber, Karin ^a   Wu, Terry H ^a   Kast, W Martin ^b   Schreiber, Hans ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHROMIUM;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; EXPERIMENTAL NEOPLASM; GENETIC VARIABILITY; IMMUNOLOGY; IMMUNOTHERAPY; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; NEOPLASM; NUDE MOUSE; RADIATION INJURY; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CHROMIUM RADIOISOTOPES; GENES, P53; IMMUNOTHERAPY; MICE; MICE, INBRED C57BL; MICE, NUDE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; NEOPLASMS, RADIATION-INDUCED; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES, CYTOTOXIC; ULTRAVIOLET RAYS; VARIATION (GENETICS);

EID: 0035293324     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Stoler, D. L., Chen, N., Basik, M., Kahlenberg, M. S., Rodriguez-Bigas, M. A., Petrelli, N. J., and Anderson, G. R. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl. Acad. Sci. USA, 96: 15121-15126, 1999.
2. Boland, C. R., and Ricciardiello, L. How many mutations does it take to make a tumor? Proc. Natl. Acad. Sci. USA, 96: 14675-14677, 1999.
3. Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., and Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science (Washington DC), 274: 2057-2059, 1996.
4. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23-29, 1976.
5. Monach, P. A., Meredith, S. C., Siegel, C. T., and Schreiber, H. A unique tumor antigen produced by a single amino acid substitution. Immunity, 2: 45-59, 1995.
6. Mumberg, D., Wick, M., and Schreiber, H. Unique tumor antigens redefined as mutant tumor-specific antigens. Semin. Immunol., 8: 289-293, 1996.
7. Schreiber, H. Tumor immunology, Ed. 4. In: W. E. Paul (ed.), Fundamental Immunology, pp. 1247-1280. New York: Lippincott Raven Press, 1999.
8. Wortzel, R. D., Urban, J. L., Philipps, C., Fitch, F. W., and Schreiber, H. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones. J. Immunol., 130: 2461-2466, 1983.
9. Urban, J. L., Van Waes, C., and Schreiber, H. Pecking order among tumor-specific antigens. Eur. J. Immunol., 14: 181-187, 1984.
10. Dudley, M. E., and Roopenian, D. C. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methyl-cholanlhrene-induced mouse sarcoma reveals secondary unique and shared antigens. J. Exp. Med., 184: 441-447, 1996.
11. Jager, E., Ringhoffer, M., Altmannsberger, M., Arand, M., Karbach, J., Jager, D., Oesch, F., and Knuth, A. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer, 71: 142-147, 1997.
12. Van Waes, C., Monach, P. A., Urban, J. L., Wortzel, R. D., and Schreiber, H. Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens, 47: 399-407, 1996.
13. Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C., Engelhard, V. H., Hunt, D. F., and Schreiber, H. The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med., 185: 695-705, 1997.
14. Ward, P. L., Koeppen, H., Hurteau, T., and Schreiber, H. Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells. J. Exp. Med., 170: 217-232, 1989.
15. Berg, R. J., van Kranen, H. J., Rebel, H. G., de Vries, A., van Vloter, W. A., Van Kreijl, C. F., van der Leun, J. C., and de Gruijl, F. R. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells. Proc. Natl. Acad. Sci. USA, 93: 274-278, 1996.
16. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., et al. Mutations in the p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
17. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
18. Wortzel, R. D., Philipps, C., and Schreiber, H. Multiple tumour-specific antigens expressed on a single tumour cell. Nature (Lond.), 304: 165-167, 1983.
19. Wortzel, R. D., Urban, J. L., and Schreiber, H. Malignant growth in the normal host after variant selection in vitro with cytolytic T-cell lines. Proc. Natl. Acad. Sci. USA, 81: 2186-2190, 1984.
20. Ward, P. L., Koeppen, H. K., Hurteau, T., Rowley, D. A., and Schreiber, H. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Cancer Res., 50: 3851-3858, 1990.
21. Dubey, P., Meredith, S. C., Siegel, C. T., and Schreiber, H. Tumor cells induce cytolytic T cells to a single immunodominant mutant peptide. J. Immunother., 21: 277-282, 1998.
22. Van Waes, C., Urban, J. L., Rothstein, J. L., Ward, P. L., and Schreiber, H. Highly malignant lumor variants retain tumor-specific antigens recognized by T helper cells. J. Exp. Med., 164: 1547-1565, 1986.
23. Kanjilal, S., Pierceall, W. E., Cummings, K. K., Kripke, M. L., and Ananthaswamy, H. N. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res., 53: 2961-2964, 1993.
24. Holmquist, G. P., and Gao, S. Somatic mutation theory, DNA repair rates, and the molecular epidemiology of p53 mutations. Mutat. Res., 386: 69-101, 1997.
25. Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., Halperin, A. J., and Ponten, J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA, 88: 10124-10128, 1991.
26. Croce, C. M., Sozzi, G., and Huebner, K. Role of FHIT in human cancer. J. Clin. Oncol., 17: 1618-1624, 1999.
27. Lacabanne, V., Viguier, M., Guillet, J. G., and Choppin, J. A wild-type p53 cytotoxic T cell epitope is presented by mouse nepatocarcinoma cells. Eur. J. Immunol., 26: 2635-2639, 1996.